University of Texas Medical Branch Researchers Find Pfizer Vaccine Effective Against New COVID-19 Strain
January 12, 2021
January 12, 2021
GALVESTON, Texas, Jan. 12 (TNSJou) -- The University of Texas Medical Branch issued the following news release:
A collaborative team from The University of Texas Medical Branch at Galveston and Pfizer has shown that the common mutation N501Y from the newly emerged SRAS-CoV-2 strains does not compromise Pfizer's COVID-19 vaccine. This is the first study to investigate if the fast-spreading new virus strains affects the vaccine's effectiveness. The study is currently available in bioR . . .
A collaborative team from The University of Texas Medical Branch at Galveston and Pfizer has shown that the common mutation N501Y from the newly emerged SRAS-CoV-2 strains does not compromise Pfizer's COVID-19 vaccine. This is the first study to investigate if the fast-spreading new virus strains affects the vaccine's effectiveness. The study is currently available in bioR . . .